The Calcium Channel Blocking (CCB) medicine sales in Canada, expressed in US Dollars PPP per capita, are predicted to initially decline from $7.2 in 2024 to $4.9 in 2028. Compared to 2023, this represents a noticeable downturn. Year-on-year forecasts indicate consistent reductions: a 8.33% decrease from 2024 to 2025, a 9.09% decrease from 2025 to 2026, an 8.33% decrease from 2026 to 2027, and an 10.91% decrease from 2027 to 2028. The Compound Annual Growth Rate (CAGR) for this period is expected to be negative, emphasizing a declining market for CCB medicines.
Future trends to watch for include:
- Increased influence of generic medicine alternatives potentially driving down prices.
- Health policy changes or new regulations which could impact the CCB segment.
- Advancements in alternative cardiac treatments that may reduce demand for CCBs.
